Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
PHASE4CompletedINTERVENTIONAL
Enrollment
13
Participants
Timeline
Start Date
August 31, 2005
Study Completion Date
November 30, 2005
Conditions
AsthmaCandidiasis, OralVoice Disorders
Interventions
DRUG
fluticasone/salmeterol DISKUS 250/50
Trial Locations (1)
92123
Allergy & Asthma Medical Group & Research Center, San Diego
All Listed Sponsors
lead
Allergy & Asthma Medical Group & Research Center
OTHER
NCT00235053 - Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID | Biotech Hunter | Biotech Hunter